StockWatch
·
Medical/Dental Instruments
Business UpdateNov 17, 2026, 04:31 PM

InspireMD to Host KOL Webinar on CGuard® Prime Carotid Stent System

AI Summary

InspireMD, Inc. announced a Key Opinion Leader (KOL) webinar scheduled for November 19, 2026, to discuss their CGuard® Prime carotid stent system. The webinar will feature six leading physician experts who will cover carotid artery disease management and the advantages of InspireMD's dual-layer mesh-covered stent technology. The CGuard® Prime system recently received FDA approval for transcarotid artery revascularization (TCAR) procedures, adding to its prior approval for transfemoral carotid artery stenting (CAS) procedures. These two methods combined represent approximately 75,000 procedures annually in the U.S.

Key Highlights

  • InspireMD to host KOL webinar on November 19, 2026, to discuss CGuard® Prime carotid stent system.
  • Webinar will feature six leading physician experts in vascular surgery, interventional cardiology, vascular medicine, and neurosurgery.
  • CGuard® Prime system received FDA approval for TCAR procedures on November 9, 2026.
  • CGuard® Prime system was previously approved by the FDA for CAS procedures in June 2025.
  • TCAR and CAS procedures combined represent an estimated 75,000 procedures annually in the U.S.